Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
Hs 578T Cediranib
0.31623
VEGFR/cKIT
RTK
 0.5611 0.05612
CAL-120 Cediranib
10.0
VEGFR/cKIT
RTK
 -0.1243 0.32979
CAL-85-1 Cediranib
0.001
VEGFR/cKIT
RTK
 1.0205 0.00078
MDA-MB-134-VI Cediranib
3.1623
VEGFR/cKIT
RTK
 0.8930 0.03528
MDA-MB-134-VI Cediranib
10.0
VEGFR/cKIT
RTK
 -0.9999 0.83082
BT-20 Cediranib
0.1
VEGFR/cKIT
RTK
 1.0807 -0.00031
CAL-85-1 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.8835 0.01447
CAL-85-1 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.3863 0.11888
Hs 578T Cediranib
0.1
VEGFR/cKIT
RTK
 0.7275 0.02636
Hs 578T Cediranib
0.031623
VEGFR/cKIT
RTK
 0.8397 0.01896
BT-20 Cediranib
0.001
VEGFR/cKIT
RTK
 1.0637 -0.00386
Hs 578T Cediranib
0.01
VEGFR/cKIT
RTK
 0.9644 0.00188
Hs 578T Cediranib
0.0031623
VEGFR/cKIT
RTK
 0.9935 0.00404
MCF7 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.7736 0.00746
MDA-MB-157 Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.0482 0.00096
Hs 578T Cediranib
1.0
VEGFR/cKIT
RTK
 0.3858 0.10669
Hs 578T Cediranib
3.1623
VEGFR/cKIT
RTK
 0.1560 0.19759
BT-20 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.8266 0.01269
BT-20 Cediranib
1.0
VEGFR/cKIT
RTK
 0.9874 0.01373
MDA-MB-157 Cediranib
0.01
VEGFR/cKIT
RTK
 0.9680 0.00658
MDA-MB-157 Cediranib
0.031623
VEGFR/cKIT
RTK
 0.8841 0.00998
Hs 578T Cediranib
10.0
VEGFR/cKIT
RTK
 -0.5723 0.81093
MCF7 Cediranib
10.0
VEGFR/cKIT
RTK
 0.1149 0.16822
PDXHCI002 Cediranib
1.0
VEGFR/cKIT
RTK
 0.6308 0.01865
PDXHCI002 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.7860 0.01648